BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38536666)

  • 1. Non-cancerous complications in HTLV-1 carriers.
    Ohmoto A; Fuji S
    Expert Rev Anti Infect Ther; 2024 May; 22(5):307-316. PubMed ID: 38536666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic diseases in patients with HTLV-1-associated uveitis.
    Nakao K; Abematsu N; Sakamoto T
    Br J Ophthalmol; 2018 Mar; 102(3):373-376. PubMed ID: 28689168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Onset of HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) and Adult T-cell Leukemia/Lymphoma (ATL): Systematic Search and Review.
    Oliveira PD; Kachimarek AC; Bittencourt AL
    J Trop Pediatr; 2018 Apr; 64(2):151-161. PubMed ID: 28582585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
    Romanelli LC; Caramelli P; Martins ML; Gonçalves DU; Proietti FA; Ribas JG; Araújo MG; Carneiro-Proietti AB
    AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1199-202. PubMed ID: 23617363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Bartholomew C; Jack N; Edwards J; Charles W; Corbin D; Cleghorn FR; Blattner WA
    J Hum Virol; 1998; 1(4):302-5. PubMed ID: 10195256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
    Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
    J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An altered maturation and adhesion phenotype of dendritic cells in diseased individuals compared to asymptomatic carriers of human T cell leukemia virus type 1.
    Manuel SL; Sehgal M; Khan ZK; Goedert JJ; Betts MR; Jain P
    AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1273-85. PubMed ID: 23750452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTLV-1: A real pathogen or a runaway guest of a diseased cell?
    Kanzaki LIB
    J Biosci; 2018 Sep; 43(4):785-795. PubMed ID: 30207322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
    Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
    J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica.
    Krämer A; Maloney EM; Morgan OS; Rodgers-Johnson P; Manns A; Murphy EL; Larsen S; Cranston B; Murphy J; Benichou J
    Am J Epidemiol; 1995 Dec; 142(11):1212-20. PubMed ID: 7485068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of HTLV-1 Infection on the Clinical Course of Patients with Rheumatoid Arthritis.
    Umekita K
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of p12K and p12R alleles of HTLV Type 1 in HAM/TSP patients and in asymptomatic HTLV type 1 carriers.
    Martins ML; Soares BC; Ribas JG; Thorun GW; Johnson J; Kroon EG; Carneiro-Prioetti AB; Bonjardim CA;
    AIDS Res Hum Retroviruses; 2002 Sep; 18(13):899-902. PubMed ID: 12230932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Matsuzaki T; Satou Y; Yasunaga J; Saito K; Arimura K; Matsuoka M; Ohara Y
    Retrovirology; 2009 Feb; 6():19. PubMed ID: 19228429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection.
    Manns A; Miley WJ; Wilks RJ; Morgan OS; Hanchard B; Wharfe G; Cranston B; Maloney E; Welles SL; Blattner WA; Waters D
    J Infect Dis; 1999 Nov; 180(5):1487-93. PubMed ID: 10515807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina.
    Benencio P; Fraile Gonzalez SA; Ducasa N; Page K; Berini CA; Biglione MM
    Retrovirology; 2020 Sep; 17(1):29. PubMed ID: 32883310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis and prevention of HTLV-1-associated diseases.
    Miwa M; Kushida S; Maeda N; Fang J; Kawamura T; Kameyama T; Uchida K
    Leukemia; 1997 Apr; 11 Suppl 3():65-6. PubMed ID: 9209300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health state utility values in people living with HTLV-1 and in patients with HAM/TSP: The impact of a neglected disease on the quality of life.
    Rosadas C; Assone T; Yamashita M; Adonis A; Puccioni-Sohler M; Santos M; Paiva A; Casseb J; Oliveira ACP; Taylor GP
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008761. PubMed ID: 33064742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.
    Enose-Akahata Y; Abrams A; Johnson KR; Maloney EM; Jacobson S
    Blood; 2012 Mar; 119(12):2829-36. PubMed ID: 22318200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.